Skip to main content
. 2014 Dec 26;6(8):6431–6447. doi: 10.18632/oncotarget.3237

Table 1. Good prognostic genes for patients of the HM cohort.

The value of the expression of each of the 350 DMC genes for predicting the EFS of the newly-diagnosed patients of the HM cohort was looked for using a Cox univariate analysis. Data are the beta coefficients, the hazard ratios and P values of the Cox model. Genes are ranked according to increasing P values.

Probe set Name Beta Coefficient HR P value
202449_s_at RXRA −0.36 0.7 0.0011
210515_at HNF1A −0.29 0.75 0.0082
220331_at CYP46A1 −0.28 0.75 0.0086
203455_s_at SAT1 −0.26 0.77 0.013
201250_s_at SLC2A1 −0.25 0.78 0.016
202436_s_at CYP1B1 −0.3 0.74 0.024
206913_at BAAT −0.23 0.79 0.025
202499_s_at SLC2A3 −0.33 0.72 0.028
228497_at SLC22A15 −0.24 0.79 0.033
205322_s_at MTF1 −0.23 0.79 0.034
206340_at NR1H4 −0.22 0.81 0.037
203814_s_at NQO2 −0.24 0.79 0.038
205896_at SLC22A4 −0.27 0.76 0.042
210301_at XDH −0.19 0.82 0.049